CompoAtlas

REPONSE ARTICULAIRE

Food supplement declared in France, declaration No 2019-3-963

REPONSE ARTICULAIRE is a food supplement declared in France. Status: retiré du marché le 16 December 2022. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
POLLENERGIE
Status
Retiré du marché le 16 December 2022
Form
Gélule
Daily dose
5 gélules
Directions for use
5 gélules par jour, de préférence à la fin des repas. En entretien, 2 à 3 gélules par jour.
Intended populations
Personnes de plus de 60 ans, Homme, Femme
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Nourrissons (moins de 1 an)
Objectives stated by the manufacturer (these are not authorised claims)
Articulations

Declaration 163333, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Glucosamine sulfate 2 KClnot declared
Sulfate de chondroïtinenot declared
Huile de poissonnot declared
Propolisnot declared

Other ingredients

Gélatine de poisson

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l’adulte. Déconseillé aux personnes allergiques aux produits de la ruche.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line